Jiangsu Hengrui Pharmaceuticals Co.,Ltd (HKG:1276)

Market Cap	440.14B
Revenue (ttm)	33.86B
Net Income (ttm)	8.16B
Shares Out	n/a
EPS (ttm)	1.27
PE Ratio	53.93
Forward PE	42.18
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000,314
Average Volume	4,280,347
Open	67.00
Previous Close	68.15
Day's Range	66.00 - 67.30
52-Week Range	52.50 - 95.20
Beta	n/a
RSI	32.93
Earnings Date	Oct 27, 2025

About HKG:1276

Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and autoimmune and other diseases. The company was founded in 1970 and is headquartered in Lianyungang, China.

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1970
• Employees: 20,238
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1276

Financial Performance

In 2024, HKG:1276's revenue was 27.98 billion, an increase of 22.63% compared to the previous year's 22.82 billion. Earnings were 6.34 billion, an increase of 47.28%.

Financial numbers in CNY